Arrestin-dependent angiotensin AT1receptor signaling regulates Akt and mTor-mediated protein synthesis

Journal of Biological Chemistry

Volumn 289, Issue 38, 2014, Pages 26155-26166

  Kendall, Ryan T ^a   Lee, Mi Hye ^a   Pleasant, Dorea L ^a   Robinson, Katherine ^a   Kuppuswamy, Dhandapani ^a,b   McDermott, Paul J ^a,b   Luttrell, Louis M ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BIOSYNTHESIS; PROTEINS; SIGNALING;

ARRESTINS; AT1-RECEPTOR; HEK-293; PROTEIN SYNTHESIS; PROTEIN TRANSLATION; RECEPTOR SIGNALING; VASCULAR SMOOTH MUSCLES;

CELL SIGNALING;

ANGIOTENSIN 1 RECEPTOR; BETA ARRESTIN 1; BETA ARRESTIN 2; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN P70; PROTEIN P85; RETINA S ANTIGEN; S6 KINASE; SHORT HAIRPIN RNA; ANGIOTENSIN II; BETA ARRESTIN; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MITOGEN ACTIVATED PROTEIN KINASE; MTOR PROTEIN, HUMAN; MULTIPROTEIN COMPLEX; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GROWTH REGULATION; NONHUMAN; PRIMARY CELL CULTURE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; ANIMAL; CYTOLOGY; HEK293 CELL LINE; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN PROCESSING;

ANGIOTENSIN II; ANIMALS; ARRESTINS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEK293 CELLS; HUMANS; MAP KINASE SIGNALING SYSTEM; MULTIPROTEIN COMPLEXES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; TOR SERINE-THREONINE KINASES;

EID: 84907211040     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.595728     Document Type: Article

References (44)

1. Proud, C. G. (2007) Signalling to translation: how signal transduction pathways control the protein synthetic machinery. Biochem. J. 403, 217-234
2. Roux, P. P., Ballif, B. A., Anjum, R., Gygi, S. P., and Blenis, J. (2004) Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. Proc. Natl. Acad. Sci. U.S.A. 101, 13489-13494
3. Rolfe, M., McLeod, L. E., Pratt, P. F., and Proud, C. G. (2005) Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenyl-ephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2). Biochem. J. 388, 973-984
4. Mukhopadhyay, N. K., Price, D. J., Kyriakis, J. M., Pelech, S., Sanghera, J., and Avruch, J. (1992) An array of insulin-activated, proline-directed ser-ine/threonine protein kinases phosphorylate the p70 S6 kinase. J. Biol. Chem. 267, 3325-3335
5. Lenormand, P., McMahon, M., and Pouysségur, J. (1996) Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-indepen-dent pathway. J. Biol. Chem. 271, 15762-15768
6. Shahbazian, D., Roux, P.P., Mieulet, V., Cohen, M.S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M., and Sonenberg, N. (2006) The mTOR/PI3K and MAPK pathways convergeoneIF4B tocontrol its phos-phorylation and activity. EMBO J. 25, 2781-2791
7. Wang, X., Li, W., Williams, M., Terada, N., Alessi, D. R., and Proud, C. G. (2001) Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J. 20, 4370-4379
8. Luttrell, L. M., Roudabush, F. L., Choy, E. W., Miller, W. E., Field, M. E., Pierce, K. L., and Lefkowitz, R. J. (2001) Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. U.S.A. 98, 2449-2454
9. Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., and Lefkowitz, R. J. (2003) Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 100, 10782-10787
10. Tohgo, A., Pierce, K. L., Choy, E. W., Lefkowitz, R. J., and Luttrell, L. M. (2002) β-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation. J. Biol. Chem. 277, 9429-9436
11. Lee, M. H., El-Shewy, H. M., Luttrell, D. K., and Luttrell, L. M. (2008) Role of β-arrestin-mediated desensitization and signaling in the control of angiotensin AT1a receptor-stimulated transcription. J. Biol. Chem. 283, 2088-2097
12. DeWire, S. M., Kim, J., Whalen, E. J., Ahn, S., Chen, M., and Lefkowitz, R. J. (2008) β-arrestin-mediated signaling regulates protein synthesis. J. Biol. Chem. 283, 10611-10620
13. Aplin, M., Christensen, G. L., Schneider, M., Heydorn, A., Gammeltoft, S., Kjølbye, A. L., Sheikh, S. P., and Hansen, J. L. (2007) Differential extracellular signal-regulated kinases 1 and 2 activation by the angiotensin type 1 receptor supports distinct phenotypes of cardiac myocytes. Basic Clin. Pharmacol. Toxicol. 100, 296-301
14. Beaulieu, J. M., Sotnikova, T. D., Yao, W. D., Kockeritz, L., Woodgett, J. R., Gainetdinov, R. R., and Caron, M. G. (2004) Lithium antagonizes do-pamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc. Natl. Acad. Sci. U.S.A. 101, 5099-5104
15. Beaulieu, J. M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R., and Caron, M. G. (2005) An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122, 261-273
16. Beaulieu, J. M., Marion, S., Rodriguiz, R. M., Medvedev, I. O., Sotnikova, T. D., Ghisi, V., Wetsel, W. C, Lefkowitz, R. J., Gainetdinov, R. R., and Caron, M. G. (2008) A β-arrestin 2 signaling complex mediates lithium action on behavior. Cell 132, 125-136
17. Ahn, S., Kim, J., Hara, M. R., Ren, X. R., and Lefkowitz, R. J. (2009) β-Ar-restin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation. J. Biol. Chem. 284, 8855-8865
18. Kendall, R. T., Strungs, E. G., Rachidi, S. M., Lee, M. H., El-Shewy, H. M., Luttrell, D. K., Janech, M. G., and Luttrell, L. M. (2011) The β-arrestin pathway-selective type 1A angiotensin receptor (AT1A) agonist [Sar1, Ile4, Ile8]angiotensin II regulates a robust G protein-independent signaling network. J. Biol. Chem. 286, 19880-19891
19. Holloway, A. C, Qian, H., Pipolo, L., Ziogas, J., Miura, S., Karnik, S., Southwell, B. R., Lew, M. J., and Thomas, W. G. (2002) Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors. Mol. Pharmacol. 61, 768-777
20. Zimmerman, B., Simaan, M., Lee, M. H., Luttrell, L. M., and Laporte, S. A. (2009) c-Src-mediated phosphorylation of AP-2 reveals a general mecha nism for receptors internalizing through the clathrin pathway. Cell Signal. 21, 103-110
21. Wilson, P. C, Lee, M. H., Appleton, K. M., El-Shewy, H. M., Morinelli, T. A., Peterson, Y. K., Luttrell, L. M., and Jaffa, A. A. (2013) The Arrestin-selective Angiotensin AT1 Receptor Agonist [Sar1, Ile4, Ile8]-AngII Negatively Regulates Bradykinin B2 Receptor Signaling via AT1-B2 Receptor Heterodimers. J. Biol. Chem. 288, 18872-18884
22. Tan, Y., Hutchison, F. N., and Jaffa, A. A. (2004) Mechanisms of angiotensin II-induced expression of B2 kinin receptors. Am. J. Physiol. Heart Circ. Physiol. 286, H926-H932
23. Saulière, A., Bellot, M., Paris, H, Denis, C, Finana, F., Hansen, J. T., Altié, M. F., Seguelas, M. H., Pathak, A., Hansen, J. L., Sénard, J. M., and Galés, C. (2012) Deciphering biased-agonism complexity reveals a new active AT(1) receptor entity. Nat. Chem. Biol. 8, 622-630
24. Christensen, G. L., Kelstrup, C. D., Lyngsø, C, Sarwar, U., Bogebo, R., Sheikh, S. P., Gammeltoft, S., Olsen, J. V., and Hansen, J. L. (2010) Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists. Mol. Cell Proteomics. 9, 1540-1553
25. Xiao, K., Sun, J., Kim, J., Rajagopal, S., Zhai, B., Villén, J., Haas, W., Kovacs, J. J., Shukla, A. K., Hara, M. R., Hernandez, M., Lachmann, A., Zhao, S., Lin, Y., Cheng, Y., Mizuno, K., Ma'ayan, A., Gygi, S. P., and Lefkowitz, R. J. (2010) Global phosphorylation analysis of β-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR). Proc. Natl. Acad. Sci. U.S.A. 107, 15299-15304
26. Hawes, B. E., Luttrell, L. M., van Biesen, T., and Lefkowitz, R. J. (1996) Phosphatidylinositol 3-kinase is an early intermediate in the G/37-medi-ated mitogen-activated protein kinase signaling pathway. J. Biol. Chem. 271, 12133-12136
27. Pullen, N, and Thomas, G. (1997) The modular phosphorylation and activation of p70s6k. FEBS Lett. 410, 78-82
28. Navé, B. T., Ouwens, M., Withers, D. J., Alessi, D. R., and Shepherd, P. R. (1999) Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344, 427-431
29. Ahn, S., Shenoy, S. K., Wei, H, and Lefkowitz, R. J. (2004) Differential kinetic and spatial patterns of β-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. J. Biol. Chem. 279, 35518-35525
30. Zimmerman, B., Beautrait, A., Aguila, B., Charles, R., Escher, E., Claing, A., Bouvier, M., Laporte, S. A. (2012) Differential β-arrestin-dependent conformational signaling and cellular responses revealed by angiotensin analogs. Sci. Signal. 5, ra33
31. Kendall, R. T., and Luttrell, L.M. (2009) Diversity in arrestin function. Cell Mol. Life Sci. 66, 2953-2973
32. Luttrell, L. M., and Miller, W. E. (2013) Arrestins as regulators of kinases and phosphatases. Prog. Mol. Biol. Transl. Sci. 118, 115-147
33. Coffa, S., Breitman, M., Hanson, S. M., Callaway, K., Kook, S., Dalby, K. N, and Gurevich, V. V. (2011) The effect of arrestin conformation on the recruitment of c-Raf1, MEK1, and ERK1/2 activation. PLoS One. 6, e28723
34. Goel, R., Phillips-Mason, P. J., Raben, D. M., and Baldassare, J. J. (2002) alpha-Thrombin induces rapid and sustained Akt phosphorylation by β-arrestin1-dependent and-independent mechanisms, and only the sustained Akt phosphorylation is essential for G1 phase progression. J. Biol. Chem. 277, 18640-18648
35. Alvarez, C. J., Lodeiro, M., Theodoropoulou, M., Camiña, J. P., Casanueva, F. F., and Pazos, Y. (2009) Obestatin stimulates Akt signalling in gastric cancer cells through β-arrestin-mediated epidermal growth factor receptor transactivation. Endocr. Relat. Cancer 16, 599-611
36. Lymperopoulos, A., and Bathgate, A. (2013) Arrestins in the cardiovascular system. Prog. Mol. Biol. Transl. Sci. 118, 297-334
37. Rajagopal, K., Whalen, E. J., Violin, J. D., Stiber, J. A., Rosenberg, P. B., Premont, R. T., Coffman, T. M., Rockman, H. A., and Lefkowitz, R. J. (2006) β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes. Proc. Natl. Acad. Sci. U.S.A. 103, 16284-16289
38. Violin, J. D., DeWire, S. M., Yamashita, D., Rominger, D. H., Nguyen, L., Schiller, K., Whalen, E.J., Gowen, M., and Lark, M. W. (2010) Selectively engaging β-arrestins at the angiotensin II type 1 receptor reduces blood pressure and increases cardiac performance. J. Pharmacol. Exp. Ther. 335, 572-579
39. Kim, K. S., Abraham, D., Williams, B., Violin, J. D., Mao, L., and Rockman, H. A. (2012) β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury. Am. J. Physiol. Heart Circ. Physiol. 303, H1001-H1010
40. Monasky, M. M., Taglieri, D. M., Henze, M., Warren, C. M., Utter, M. S., Soergel, D. G., Violin, J. D., and Solaro, R. J. (2013) The β-arrestin-Biased Ligand TRV120023 Inhibits Angiotensin II-Induced Cardiac Hypertrophy While Preserving Enhanced Myofilament Response to Calcium. Am. J. Physiol. Heart Circ Physiol. 10.1152/ajpheart. 00327.2013
41. Kim, J., Zhang, L., Peppel, K., Wu, J. H, Zidar, D. A., Brian, L., DeWire, S. M., Exum, S. T., Lefkowitz, R. J., and Freedman, N. J. (2008) β-Arrestins regulate atherosclerosis and neointimal hyperplasia by controlling smooth muscle cell proliferation and migration. Circ. Res. 103, 70-79
42. Kim, J., Ahn, S., Rajagopal, K., and Lefkowitz, R. J. (2009) Independent β-arrestin2 and Gq/protein kinase Cf pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor. J. Biol. Chem. 284, 11953-11962
43. Lymperopoulos, A., Rengo, G., Zincarelli, C, Kim, J., Soltys, S., and Koch, W. J. (2009) An adrenal β-arrestin 1-mediated signaling pathway underlies angiotensin II-induced aldosterone production in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 106, 5825-5830
44. Lymperopoulos, A., Rengo, G., Zincarelli, C, Kim, J., and Koch, W. J. (2011) Adrenal β-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels. J. Am. Coll. Cardiol. 57, 356-365